Overcoming Chemotherapy Resistance in SCLC
- PMID: 34358725
- DOI: 10.1016/j.jtho.2021.07.018
Overcoming Chemotherapy Resistance in SCLC
Abstract
SCLC is an aggressive form of lung cancer with a very poor prognosis. Although SCLC initially responds very well to platinum-based chemotherapy, it eventually recurs and at recurrence is nearly universally resistant to therapy. In light of the recent advances in understanding regarding the biology of SCLC, we review findings related to SCLC chemotherapy resistance. We discuss the potential clinical implications of recent preclinical discoveries in altered signaling pathways, transcriptional landscapes, metabolic vulnerabilities, and the tumor microenvironment.
Keywords: Chemoresistance; Chemotherapy; Resistance; SCLC; Small cell lung cancer.
Copyright © 2021. Published by Elsevier Inc.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
